doi: 10.1073/pnas.072090199 49 ScottK
Finally, the study found that the largest predictor of triglyceride lowering in the tirzepatide groups was change in apoC-III levels and not body weight [60]
Growing up in New York, Unger completed his medical degree at Columbia University and then directed a project to detect diabetes for the US Public Health Services
Greater weight loss efficacy of tirzepatide 10 mg ( 3.2 kg) and 15 mg ( 5.2 kg) compared to semaglutide was also observed in an indirect comparison with data from the SUSTAIN FORTE study, where semaglutide was administered at the maximum hypoglycemic dose of 2.0 mg [49]
This variability likely reflects differences in study populations, such as the presence or absence of T2DM, degree of obesity, sex distribution, and comorbid conditions, as well as differences in intervention characteristics, including the type, dose, and duration of GLP-1 RA therapy
Cardiovascularkidneymetabolic health: a presidential advisory from the American Heart Association